Marino Hails Senate Passage of Prescription Drug Enforcement Legislation
Washington, D.C. – Congressman Tom Marino (PA-10) applauded the U.S. Senate’s passage of S.483, the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. Marino was the sponsor of companion signature prescription drug diversion legislation (H.R. 471) which passed in the House on April 21, 2015.
On Thursday, this bill passed in the Senate by unanimous consent and heads back to the House for a final vote. It offers a critical and comprehensive approach to combat prescription drug abuse by increasing collaboration between the Drug Enforcement Agency (DEA), prescription drug distributors and pharmacies. However, a central tenant to its bipartisan support was the strong protections of patients’ access to important medicines. The bill also directs intergovernmental agency collaboration and integration regarding drug abuse enforcement and preserving patient accessibility between the Department of Health and Human Services (HHS), the Office of National Drug Control Policy (ONDCP) and the DEA.
“I am pleased the Senate recognized this bill will protect access and improves enforcement outcomes," said Rep. Marino. "It is now common knowledge that prescription drug abuse is an epidemic and yet sometimes the solutions to abuse have restricted legitimate patients access to the drugs they require. Its passage signals our commitment to a safer and healthier America.”